|
- Trimtech Therapeutics
TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases 05 March 2025
- TRIMTECH Therapeutics raises $31M seed funding to advance targeted . . .
TRIMTECH is leveraging the innate properties of the E3 ubiquitin ligase TRIM21 to selectively and potently degrade protein aggregates associated with a range of diseases which are not well served by current TPD approaches
- Cow and Horse Hoof Trimming Products - Cattle Hoof Trimming – Trim-Tec
Explore precision hoof care with Trim Tec! We offer a unique line of cow and horse hoof trimming products Elevate your livestock maintenance with top-tier blades, wheels, and accessories Shop now
- Trimtech closes $31m to advance CNS therapeutics pipeline
Trimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance its pipeline of the central nervous system (CNS)-penetrant therapeutics that are based on Trimtacs, the aggregate-selective degrader molecules
- Control Valves - TrimTeck
Severe Service valves are the most robust and specialized valves in Trimteck’s product lineup, built to withstand the harshest conditions in industrial applications Severe Service Valves are designed to tackle extreme service conditions, such as high pressure drops that result in severe cavitation, flashing, choking, or noise
- TRIMTECH Therapeutics raises $31M seed funding to advance targeted . . .
TRIMTECH is leveraging the innate properties of the E3 ubiquitin ligase TRIM21 to selectively and potently degrade protein aggregates associated with a range of diseases which are not well served
- TRIMTECH Therapeutics - Cambridge Innovation Capital
TRIMTECH Therapeutics is creating a differentiated portfolio of potent, highly specific degraders, known as TRIMTACs™ and TRIMGLUEs™, that selectively target the removal of toxic proteins for the treatment of intractable CNS and inflammatory disorder
|
|
|